• A new multicenter study across three major medical institutions demonstrates Daxor's Blood Volume Analysis (BVA) provides superior accuracy over conventional pressure-based measurements in heart failure patients.
• Research published in the Journal of Cardiac Failure reveals BVA's unique ability to detect anemia and identify sex-specific volume differences, enabling more personalized treatment approaches.
• The study, analyzing 255 heart failure patients, confirms BVA's 98% accuracy in volume assessment, highlighting its potential to improve patient outcomes through precise diagnosis.